CTX-M extended-spectrum β-lactamase-producing Klebsiella spp, Salmonella spp, Shigella spp and Escherichia coli isolates in Iranian hospitals

Brazilian Journal of Microbiology

Volumn 47, Issue 3, 2016, Pages 706-711

  Bialvaei, Abed Zahedi ^a   Kafil, Hossein Samadi ^b   Asgharzadeh, Mohammad ^c   Aghazadeh, Mohammad ^a   Yousefi, Mehdi ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CTX M; ESBL; Escherichia coli; Klebsiella spp; Multi drug resistant; Salmonella spp; Shigella spp

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE;

CROSS INFECTION; CROSS-SECTIONAL STUDY; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; HUMAN; IRAN; KLEBSIELLA; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; SALMONELLA; SHIGELLA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; CROSS-SECTIONAL STUDIES; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; HUMANS; IRAN; KLEBSIELLA; MICROBIAL SENSITIVITY TESTS; SALMONELLA; SHIGELLA;

EID: 84990938426     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1016/j.bjm.2016.04.020     Document Type: Article

References (30)

1. 1 Bradford, P.A., Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14 (2001), 933–951.
2. 2 Tzouvelekis, L., Tzelepi, E., Tassios, P., Legakis, N., CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 14 (2000), 137–142.
3. 3 Canton, R., Coque, T.M., The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9 (2006), 466–475.
4. 4 Lartigue, M., Poirel, L., Decousser, J., Nordmann, P., Multidrug-resistant Shigella sonnei and Salmonella enterica serotype Typhimurium isolates producing CTX-M β-lactamases as causes of community-acquired infection in France. Clin Infect Dis 40 (2005), 1069–1070.
5. 5 Barthelemy, M., Peduzzi, J., Bernard, H., et al. ended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca. Biochim Biophys Acta 1122 (1992), 15–22.
6. 6 Lahlaoui, H., Khalifa, A.B.H., Moussa, M.B., Epidemiology of Enterobacteriaceae producing CTX-M type extended spectrum β-lactamase (ESBL). Med Malad Infect 44 (2014), 400–404.
7. 7 Humeniuk, C., Arlet, G., Gautier, V., et al. β-Lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types. Antimicrob Agents Chemother 46 (2002), 3045–3049.
8. 8 Poirel, L., Kämpfer, P., Nordmann, P., Chromosome-encoded Ambler class A β-lactamase of Kluyvera georgiana, a probable progenitor of a subgroup of CTX-M extended-spectrum β-lactamases. Antimicrob Agents Chemother 46 (2002), 4038–4040.
9. 9 Saladin, M., Cao, V.T., Lambert, T., et al. Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209 (2002), 161–168.
10. 10 Hawkey, P.M., Prevalence and clonality of extended-spectrum β-lactamases in Asia. Clin Microbiol Infect 14 (2008), 159–165.
11. 11 Behrooozi, A., Rahbar, M., Yousefi, J.V., Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebsiella pneumoniae isolated from urine in an Iranian 1000-bed tertiary care hospital. Afr J Microbiol Res 4 (2010), 881–884.
12. 12 Koneman, W., Allen Stephan, D., Color atlas and text book of diagnostic microbiology. 1997, Lippincott, Philadelphia, NY.
13. 13 Jarlier, V., Nicolas, M.H., Fournier, G., Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 10 (1988), 867–878.
14. 14 Thomson, K.S., Sanders, C.C., Detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother 36 (1992), 1877–1882.
15. 15 al Naiemi, N., Duim, B., Bart, A., A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Med Microbiol 55 (2006), 1607–1608.
16. 16 Yershov, G., Barsky, V., Belgovskiy, A., DNA analysis and diagnostics on oligonucleotide microchips. PNAS 93 (1996), 4913–4918.
17. 17 Sturenburg, E., Mack, D., Extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47 (2003), 273–295.
18. CTX-M genes in Enterobacteriaceae. Apmis 115 (2007), 1400–1408.
19. 19 Bialvaei, A.Z., Kafil, H.S., Colistin, mechanisms and prevalence of resistance. Curr Med Res Opin 31 (2015), 707–721.
20. 20 Kim, J., Lim, Y.M., Prevalence of CTX-M extended-spectrum beta-lactamases in clinical isolates of entrobacteriaceae in Korea. J Bacteriol Virol 34 (2004), 303–310.
21. 21 Feizabadi, M.M., Mahamadi-Yeganeh, S., Mirsalehian, A., et al. Genetic characterization of ESBL producing strains of Klebsiella pneumoniae from Tehran hospitals. J Infect Dev Ctries 4 (2010), 609–615.
22. 22 Mirzaee, M., Pourmand, M., Chitsaz, M., Mansouri, S., Antibiotic resistance to third generation cephalosporins due to CTX-M-type extended-spectrum β-lactamases in clinical isolates of Escherichia coli. Iran J Pub Health 38 (2009), 10–17.
23. 23 Ramazanzadeh, R., Chitsaz, M., Bahmani, N., Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing bacteria in intensive care units of Sanandaj general hospitals (Kurdistan, Iran). Chemotherapy 55 (2009), 287–292.
24. 24 Stobberingh, E., Arends, J., Hoggkamp-Korstanje, J., Occurrence of extended-spectrum betalactamases (ESBL) in Dutch hospitals. Infect 27 (1999), 348–354.
25. 25 Nordmann, P., Poirel, L., Kubina, M., et al. Biochemical-genetic characterization and distribution of OXA-22, a chromosomal and inducible class D beta-lactamase from Ralstonia (Pseudomonas pickettii). Antimicrob Agents Chemother 44 (2000), 2201–2204.
26. 26 Ho, P.L., Tsang, D.N., Que, T.L., et al. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among Escherichia coli and Klebsiella species in Hong Kong. Apmis 108 (2000), 237–240.
27. 27 Cheong, Y., Lim, V., Jegathesan, M., Suleiman, A., Antimicrobial resistance in 6 Malaysian general hospitals. Med J Malaysia 49 (1994), 317–326.
28. 28 Pitout, J.D., Laupland, K.B., Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8 (2008), 159–166.
29. 29 Bialvaei, A.Z., Kafil, H.S., Asgharzadeh, M., et al. Current methods for the identification of carbapenemases. J Chemother, 2015, 10.1179/1973947815Y.0000000063.
30. 30 Reynolds, R., Hope, R.D.M.L., Activity of Doripenem in the context of rising antimicrobial resistance in invasive Entrobacteriaceae in the UK and Ireland. 46th ICAAC, San Francisco, 2006, C2–C0065.